Paper Details
- Home
- Paper Details
Waddling Gait: A complication of valproate therapy and a thought beyond vitamin D deficiency.
Author: ChouhanDushyant K, GuptaSumit, NarangAmit, SharmaAmit, SinhaSiddhartha
Original Abstract of the Article :
Proximal muscle weakness is a common presentation in paediatric-orthopaedic clinics and is frequently paired with a vitamin D deficiency diagnosis. Recently, side effects of the extensive use of antiepileptic and antipsychotic drugs such as sodium valproate in childhood disorders are being documente...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065696/
データ提供:米国国立医学図書館(NLM)
Waddling Gait: A Complication of Valproate Therapy and a Thought Beyond Vitamin D Deficiency
Proximal muscle weakness, characterized by difficulty in moving the arms and legs, is a common presentation in pediatric orthopedic clinics. While vitamin D deficiency is often considered a primary cause, this study highlights the potential role of sodium valproate, a medication commonly used for epilepsy and mood disorders, as a contributing factor. The study presents a case of a 13-year-old girl who developed proximal myopathy, a condition affecting the muscles, while taking sodium valproate, risperidone, and trihexyphenidyl.
Sodium Valproate's Potential Role: A Shadow in the Desert of Muscle Weakness
The study suggests that sodium valproate can cause drug-induced proximal myopathy, a potentially serious side effect. The patient in this case experienced a waddling gait, a characteristic symptom of proximal myopathy, which was initially attributed to vitamin D deficiency. However, after replacing sodium valproate with another medication and providing carnitine supplementation, the patient fully recovered. This highlights the importance of considering drug-induced myopathy as a potential cause of proximal muscle weakness, particularly in patients taking medications like sodium valproate.
Navigating Muscle Weakness: A Desert of Potential Causes
This case report reminds us that the desert of medical knowledge is vast, and we must be vigilant in exploring potential causes of medical conditions. Attributing muscle weakness solely to vitamin D deficiency might overlook other contributing factors, such as drug-induced myopathy. This underscores the importance of comprehensive medical evaluation and careful consideration of medication-related side effects.
Dr.Camel's Conclusion
This case study highlights the importance of considering drug-induced myopathy as a potential cause of proximal muscle weakness, particularly in patients taking medications like sodium valproate. It reminds us to explore all possibilities in diagnosing and treating medical conditions, ensuring patients receive the most appropriate and effective care.
Date :
- Date Completed 2020-11-12
- Date Revised 2020-11-12
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.